News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Investor Sues Abbott Laboratories Over Discontinued Stent
December 19, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHICAGO, Dec 18 (Reuters) - An investor sued Abbott Laboratories (ABT.N: Quote, Profile, Research) for halting development of the ZoMaxx stent, saying the healthcare company breached an obligation when it dropped the product.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Abbott Laboratories
MORE ON THIS TOPIC
Policy
FDA Commissioner Marty Makary Proposes Lowering Industry User Fees
July 15, 2025
·
2 min read
·
Tristan Manalac
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
·
6 min read
·
Lori Ellis
FDA
FDA Rejections: We Read 200 CRLs So You Don’t Have To
July 11, 2025
·
5 min read
·
Annalee Armstrong
Complete response letters
FDA Publishes Cache of Complete Response Letters in Bid for ‘Radical Transparency’
July 10, 2025
·
2 min read
·
Dan Samorodnitsky